Sleep apnea, sleep-disordered breathing, and intermittent
hypoxia have been identified and linked in latest research to
almost all major fatal medical conditions, from heart attack,
stroke, diabetes, COPD cancer, and major depressive disorders.
Current main-stream treatment options are unsatisfactory, and
the entire world is looking for a better or best solution.
This market is one of the most explosive and largely untapped
markets.
SleepApneaUSA.net, founded by Dr. Jin Zhou, relied upon
the latest research and clinically developed ZHT - Zhou's
Hypoxicology Therapy to discover a possible cure for sleep apnea
and provide an alternative care to those who can't tolerate
CPAP,"sleeping mask".
We are looking for
visionary investors, strategic partners, business alliance and
concerned healthcare providers to advance our goals, to find and
provide with possible cure for sleep apnea, and its related
major fatal medical conditions.
This web site is
mainly for visionary investors, strategic business partners and
concerned healthcare providers.
The 15 leading causes (table B) remainedthe same for 2002
and 2003 except that Assault (homicide)dropped out of the
15 leading causes in 2003 and Parkinson’s disease entered
the list as the 14th leading cause. The 15 leading causes
of death in 2003 were as follows:
1) Diseases of heart;
2) Malignant neoplasms;
3) Cerebrovascular diseases;
4) Chronic lower respiratory diseases;
5) Accidents (unintentional injuries);
6) Diabetes mellitus;
7) Influenza and pneumonia;
8) Alzheimer’s disease;
9) Nephritis, nephrotic syndrome and nephrosis;
10) Septicemia;
11) Intentional self-harm (suicide);
12) Chronic liver disease and cirrhosis;
13) Essential (primary) hypertension and hypertensive
renal disease;
14) Parkinson’s disease;
15) Pneumonitis due to solids and liquids."
"A new study shows that undiagnosed sleep
apnea, a common disorder associated with snoring, may
decrease women's sexual function by reducing sexual desire ..."
"The diagnosis of ED
could become a powerful clinical tool to improve early
detection of atherosclerosis and initiate prompt
aggressive medical management of associated
cardiovascular risk factors. International Journal of
Impotence Research (2005) 17, S19-S24.
doi:10.1038/sj.ijir.3901425."
Sex and the heart.
Int J Impot Res. 2005 Dec;17 Suppl 1:S4-6.
PMID: 16391542 [PubMed - in process]
"Some unique organic
and psychological factors contributing to ED have been
identified in patients with underlying cardiovascular
problems. Certain risk factors are common to the
development of
coronary artery disease, heart failure and ED, including
diabetes mellitus, hypertension, smoking and
dyslipidemia. Additionally, the use of
medications such as beta blockers, digoxin and thiazide
diuretics might eventually cause but more likely worsen
sexual dysfunction. These unintended consequences can lead
to medical noncompliance in misguided efforts to retain
satisfactory sexual activity, and thereby worsen
cardiovascular problems. Accordingly, it is
important for physicians dealing with patients with
cardiovascular diseases to address sexual concerns in
their patients."
Reversible ventricular
arrhythmia in REM sleep associated with hypoxic
sleep-disordered breathing. Sleep Med. 2006
Jan;7(1):81-2. Epub 2005 Nov 28. No abstract available.
PMID: 16314147 [PubMed - in process]
"CONCLUSIONS: ED in
OSAS is related to nocturnal hypoxemia, and about
75% of OSAS
patients with ED treated with nasal CPAP showed
remission at one-month follow-up, resulting in
significant improvement in quality of life."
Predictors of erectile
function improvement in obstructive sleep apnea patients
with long-term CPAP treatment.
Int J Impot Res. 2005 Mar-Apr;17(2):186-90.
PMID: 15510189 [PubMed - indexed for MEDLINE]
Erectile dysfunction in men
with obstructive sleep apnea syndrome: a randomized study
of the efficacy of sildenafil and continuous positive
airway pressure.
Int J Impot Res. 2004 Jun;16(3):256-60.
PMID: 15057257 [PubMed - indexed for MEDLINE]
"we conclude that a
combination of the two therapeutic tools or a different
therapeutic mode should be studied further."
[Obstructive sleep apnea
and erectile dysfunction] Zhonghua Yi Xue Za
Zhi. 2005 Jan 12;85(2):141-2. Review. Chinese. No
abstract available.
PMID: 15774230 [PubMed - indexed for MEDLINE]
[Treatment for erectile
dysfunction patients with obstructive sleep apnea syndrome
by nasal continual positive airway pressure]
Zhonghua Nan Ke Xue. 2004 May;10(5):355-7. Chinese.
PMID: 15190828 [PubMed - indexed for MEDLINE]
Severe, but not mild,
obstructive sleep apnea syndrome is associated with
erectile dysfunction. Urology. 2004
Mar;63(3):545-9.
PMID: 15028455 [PubMed - indexed for MEDLINE]
Erectile dysfunction in men
with obstructive sleep apnea: an early sign of nerve
involvement. Sleep. 2000 Sep
15;23(6):775-81.
PMID: 11007444 [PubMed - indexed for MEDLINE]
Use, misuse and abuse of
androgens. The Endocrine Society of Australia consensus
guidelines for androgen prescribing. Med J Aust.
2000 Mar 6;172(5):220-4. Erratum in: Med J Aust 2000 Apr
3;172(7):334.
PMID: 10776394 [PubMed - indexed for MEDLINE]
[Sleep apnea and erectile
dysfunction]
Dtsch Med Wochenschr. 1999 May 21;124(20):631-5.
Review. German. No abstract available.
PMID: 10370386 [PubMed - indexed for MEDLINE]
The prevalence of erectile
dysfunction in men visiting outpatient clinics.
Int J Impot Res. 2006 Jan 5; [Epub ahead of print]
PMID: 16395328 [PubMed - as supplied by publisher]
A multidisciplinary
approach to assess erectile dysfunction in high-risk
cardiovascular patients.
Int J Impot Res. 2005 Dec;17 Suppl 1:S37-43.
PMID: 16391541 [PubMed - in process]
Why do patients with heart
failure suffer from erectile dysfunction? A critical
review and suggestions on how to approach this problem.
Int J Impot Res. 2005 Dec;17 Suppl 1:S25-36.
PMID: 16391540 [PubMed - in process]
Efficacy and tolerability
of vardenafil in men with mild depression and erectile
dysfunction: the depression-related improvement with
vardenafil for erectile response study. Am J
Psychiatry. 2006 Jan;163(1):79-87.
PMID: 16390893 [PubMed - in process]
The prevalence of erectile
dysfunction in men visiting outpatient clinics.
Int J Impot Res. 2006 Jan 5; [Epub ahead of print]
PMID: 16395328 [PubMed - as supplied by publisher]
Why do patients with heart
failure suffer from erectile dysfunction? A critical
review and suggestions on how to approach this problem.
Int J Impot Res. 2005 Dec;17 Suppl 1:S25-36.
PMID: 16391540 [PubMed - in process]
Prevention and management
of cardiovascular disease and erectile dysfunction: toward
a common patient-centered, care model. Am J
Cardiol. 2005 Dec 26;96(12 Suppl 2):80-4. Epub 2005
Dec 6.
PMID: 16387574 [PubMed - in process]
Cardiovascular issues in
hypogonadism and testosterone therapy. Am J
Cardiol. 2005 Dec 26;96(12 Suppl 2):67-72. Epub
2005 Dec 19.
PMID: 16387571 [PubMed - in process]
Sexual dysfunction and
cardiovascular disease: integrative concepts and
strategies. Am J
Cardiol. 2005 Dec 26;96(12 Suppl 2):57-61. Epub
2005 Nov 15.
PMID: 16387569 [PubMed - in process]
Phosphodiesterase 5
inhibition in chronic heart failure and pulmonary
hypertension. Am J
Cardiol. 2005 Dec 26;96(12 Suppl 2):47-51. Epub
2005 Dec 5.
PMID: 16387567 [PubMed - in process]
Cardiac safety in clinical
trials of phosphodiesterase 5 inhibitors. Am J
Cardiol. 2005 Dec 26;96(12 Suppl 2):37-41. Epub
2005 Dec 5.
PMID: 16387565 [PubMed - in process]
